News
KOAN
0.0047
+4.44%
0.0002
Weekly Report: what happened at KOAN last week (1124-1128)?
Weekly Report · 3d ago
Weekly Report: what happened at KOAN last week (1117-1121)?
Weekly Report · 11/24 09:28
Weekly Report: what happened at KOAN last week (1110-1114)?
Weekly Report · 11/17 09:28
Weekly Report: what happened at KOAN last week (1103-1107)?
Weekly Report · 11/10 09:27
Weekly Report: what happened at KOAN last week (1027-1031)?
Weekly Report · 11/03 09:27
Apollo Biowellness, Inc., Corporate Status and Merger Update
Newsfile · 10/29 13:30
Weekly Report: what happened at KOAN last week (1020-1024)?
Weekly Report · 10/27 09:29
Weekly Report: what happened at KOAN last week (1013-1017)?
Weekly Report · 10/20 09:28
Weekly Report: what happened at KOAN last week (1006-1010)?
Weekly Report · 10/13 09:28
Apollo Biowellness, Inc., Merger Update
Newsfile · 10/09 18:48
Apollo Biowellness, Inc., Re-Engages GSS Capital
Newsfile · 10/08 13:30
Weekly Report: what happened at KOAN last week (0929-1003)?
Weekly Report · 10/06 09:27
Weekly Report: what happened at KOAN last week (0922-0926)?
Weekly Report · 09/29 09:28
Weekly Report: what happened at KOAN last week (0915-0919)?
Weekly Report · 09/22 09:28
Apollo Biowellness, Inc., to Merge with Revive Regenerative, Inc.
Newsfile · 09/17 13:30
Weekly Report: what happened at KOAN last week (0908-0912)?
Weekly Report · 09/15 10:05
Weekly Report: what happened at KOAN last week (0901-0905)?
Weekly Report · 09/08 10:06
Weekly Report: what happened at KOAN last week (0825-0829)?
Weekly Report · 09/01 10:04
Weekly Report: what happened at KOAN last week (0818-0822)?
Weekly Report · 08/25 10:09
Apollo Biowellness, Inc., Launches New Product Brand
Newsfile · 08/21 13:30
More
Webull provides a variety of real-time KOAN stock news. You can receive the latest news about Resonate Blends Inc through multiple platforms. This information may help you make smarter investment decisions.
About KOAN
Apollo Biowellness, Inc., and its subsidiary, Evolutionary Biologics, Inc., is engaged in the discovery, development and marketing of products designed to better mankind. The Company is engaged in the field of regenerative medicine using biologic-based products. Its products are intended to market under third-party label exemptions. The Company is focused on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. It is licensed under a patent-pending application to market a dual-acting all-natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Its products are being developed for consumer and professional markets.